In 2022, the FDA approved tirzepatide for T2D treatment method beneath the manufacturer identify Mounjaro depending on the SURPASS method results, which demonstrated a reduction of around -three.02% in glycated hemoglobin. It is actually administered in weekly doses of up to 15mg [1, thirty]. Tirzepatide has also proven favourable leads to the SURM